Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yan Hu

1PUBLICATIONS

9CO-AUTHORS

Otorhinolaryngology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Feb 15, 2024

Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial.

Shuangshuang Xing, Yiqin Pu, Xiaoqian Zhao

Pageof 1

Frequent Collaborators

1 joint publications

Shuangshuang Xing

1 joint publications

Yiqin Pu

1 joint publications

Xiaoqian Zhao

1 joint publications

Feiyan Zhang

1 joint publications

Zejuan Gu

1 joint publications

Wei Xu

1 joint publications

Lei Fan

1 joint publications

Yi Miao

1 joint publications

Jianyong Li

Frequent Collaborators

1 joint publications

Shuangshuang Xing

1 joint publications

Yiqin Pu

1 joint publications

Xiaoqian Zhao

1 joint publications

Feiyan Zhang

Top Related Videos

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on : Jun 21, 2024

See more related videos

Top Related Videos

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on : Jun 21, 2024

See more related videos